Home » Authors » Trista Morrison

Trista Morrison

Articles

ARTICLES

CytRx Spins Out RNAi Programs To Form Subsidiary RXi Pharma

Jan. 11, 2007

By Trista Morrison

CytRx Spins Out RNAi Programs To Form Subsidiary RXi Pharma

Jan. 11, 2007

By Trista Morrison

Biogen Idec Acquires Syntonix, Moves Into Hemophilia Arena

Jan. 5, 2007

By Trista Morrison

Biogen Idec Acquires Syntonix, Moves Into Hemophilia Arena

Jan. 5, 2007

By Trista Morrison

Biomira Launches Clinical Trials Of Cancer-Fighting Therapies

Jan. 3, 2007

By Trista Morrison

Biomira Launches Clinical Trials Of Cancer-Fighting Therapies

Jan. 3, 2007

By Trista Morrison

Paramount-Backed Tikvah Makes Reduced-Risk CNS Play

Dec. 29, 2006

By Trista Morrison

Paramount-Backed Tikvah Makes Reduced-Risk CNS Play

Dec. 29, 2006

By Trista Morrison

EpiCept Licenses Bupivacaine Patch IP To Durect For $10M

Dec. 27, 2006

By Trista Morrison

Ardea Biosciences Acquires Valeant's Early Programs

Dec. 27, 2006

By Trista Morrison

View All Articles by Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...